Article info

Download PDFPDF
Tumour necrosis factor blockade mediates altered serotonin transporter availability in rheumatoid arthritis: a clinical, proof-of-concept study
  1. Correspondence to Dr Jonathan Cavanagh, Sackler Institute of Psychobiological Research, Faculty of Medicine University of Glasgow, Southern General Hospital, Glasgow G51 4TF, UK; Jonathan.Cavanagh{at}clinmed.gla.ac.uk
View Full Text

Citation

Cavanagh J, Paterson C, McLean J, et al
Tumour necrosis factor blockade mediates altered serotonin transporter availability in rheumatoid arthritis: a clinical, proof-of-concept study

Publication history

  • Accepted June 27, 2009
  • First published April 6, 2010.
Online issue publication 
May 24, 2010

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.